Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

61. Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance

Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance 28418742 2017 10 31 2018 11 13 2326-5108 15 2 2017 Mar/Apr Health security Health Secur Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance. 154-164 10.1089/hs.2016.0104 Taiwan's National Laboratory System is one of the action packages of the Global Health Security Agenda, which was launched by the World Health Organization (WHO) to promote health (...) the national laboratory system for public health in Taiwan. We provide additional information on the national influenza laboratory surveillance network to demonstrate how our national laboratory systems work in practice, including descriptions of long-term seasonal influenza characterization and successful experiences identifying novel H7N9 and H6N1 influenza viruses. Yang Ji-Rong JR Teng Hwa-Jen HJ Liu Ming-Tsan MT Li Shu-Ying SY eng Journal Article United States Health Secur 101654694 2326-5094 IM

Health security2017 Full Text: Link to full Text with Trip Pro

62. Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study

Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study 28466053 2018 11 13 2347-3584 28 1 2017 Mar Virusdisease Virusdisease Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study. 33-38 10.1007/s13337-017-0363-y Recently, India reported an increase in swine flu (influenza A H1N1) activity. There are limited studies on epidemiology of swine flu in Indian context. This study aims (...) to analyze clinical and epidemiological profile of suspected swine flu cases in central India. 171 cases were included in a hospital based, observational, descriptive study conducted from December 2014 to April 2015. Demographics, clinical presentation and outcome of positive and negative cases were compared. Data was analyzed using STATA software. Distribution by age, sex and residence was found similar ( p > 0.05) in positive and negative cases. Cough (89%), fever (85%) and throat irritation (51%) were

Virusdisease2017 Full Text: Link to full Text with Trip Pro

63. Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord

Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord WHO IRIS: Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord Browse Related links Files in This Item: File (...) Description Size Format 1.2 MB Adobe PDF Title: Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord Authors: Issue Date: 17-Mar-2017 Publisher: World Health Organization = Organisation mondiale de la Santé Journal: 92 (11): 117-128 Place of publication: Geneva = Genève Language: English French Description: 12 p Subject: URI: Appears

WHO2017

64. Influenza.

Influenza. Influenza is an acute respiratory illness, caused by influenza A, B, and C viruses, that occurs in local outbreaks or seasonal epidemics. Clinical illness follows a short incubation period and presentation ranges from asymptomatic to fulminant, depending on the characteristics of both the virus and the individual host. Influenza A viruses can also cause sporadic infections or spread worldwide in a pandemic when novel strains emerge in the human population from an animal host. New (...) approaches to influenza prevention and treatment for management of both seasonal influenza epidemics and pandemics are desirable. In this Seminar, we discuss the clinical presentation, transmission, diagnosis, management, and prevention of seasonal influenza infection. We also review the animal-human interface of influenza, with a focus on current pandemic threats. Copyright © 2017 Elsevier Ltd. All rights reserved.

Lancet2017

65. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 WHO IRIS: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 Browse Related links Files in This Item: File Description Size Format 590.82 kB Adobe PDF Title: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 Other Titles: Influenza Bulletin Authors: Issue Date: Mar-2017 (...) Publisher: World Health Organization. Regional Office for Africa Relation: Influenza Virological Surveillance in the WHO African Region 10 3 Place of publication: Brazzaville Language: English Description: 3 p. Subject: Context: diagnosis URI: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

66. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 WHO IRIS: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 Browse Related links Files in This Item: File Description Size Format 591.78 kB Adobe PDF Title: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 Authors: Issue Date: Mar-2017 Publisher: World Health Organization (...) . Regional Office for Africa Relation: Influenza Virological Surveillance in the WHO African Region 11 3 Place of publication: Brazzaville Language: English Description: 3 p. Subject: URI: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

67. Community-Level Differences in the Microbiome of Healthy Wild Mallards and Those Infected by Influenza A Viruses

Community-Level Differences in the Microbiome of Healthy Wild Mallards and Those Infected by Influenza A Viruses 28293681 2018 11 13 2379-5077 2 1 2017 Jan-Feb mSystems mSystems Community-Level Differences in the Microbiome of Healthy Wild Mallards and Those Infected by Influenza A Viruses. e00188-16 10.1128/mSystems.00188-16 Waterfowl, especially ducks and geese, are primary reservoirs for influenza A viruses (IAVs) that evolve and emerge as important pathogens in domestic animals and humans (...) predictive of infection status. IMPORTANCE Seasonal influenza causes 3 to 5 million severe illnesses and 250,000 to 500,000 human deaths each year. While pandemic influenza viruses emerge only periodically, they can be devastating-for example, the 1918 H1N1 pandemic virus killed more than 20 million people. IAVs infect the respiratory tract and cause significant morbidity and mortality in humans. In contrast, IAVs infect the gastrointestinal tract of waterfowl, producing little pathology. Recent studies

mSystems2017 Full Text: Link to full Text with Trip Pro

68. [Economic evaluation of the molecular diagnosis of the influenza virus]

[Economic evaluation of the molecular diagnosis of the influenza virus] Évaluation économique du diagnostic moléculaire du virus influenza [Economic evaluation of the molecular diagnosis of the influenza virus] Évaluation économique du diagnostic moléculaire du virus influenza [Economic evaluation of the molecular diagnosis of the influenza virus] Bélanger S, Martin G Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Bélanger S, Martin G. Évaluation économique du diagnostic moléculaire du virus influenza. [Economic evaluation of the molecular diagnosis of the influenza virus] Quebec: Institut national d'excellence en sante et en services sociaux (INESSS). 2016 Authors' conclusions Introducing rapid RT-PCR, in replacement of RDTs and the traditional RT-PCR technique, to diagnose influenza could make tests self-financing and would product

Health Technology Assessment (HTA) Database.2017

69. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis 28299371 2018 11 13 2468-2667 2 2 2017 Feb The Lancet. Public health Lancet Public Health Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. e74-e81 10.1016/S2468-2667(16)30044-5 In 2013 England and Wales began to fund a live (...) attenuated influenza vaccine programme for individuals aged 2-16 years. Mathematical modelling predicts substantial beneficial herd effects for the entire population as a result of reduced influenza transmission. With a decreased influenza-associated disease burden, existing immunisation programmes might be less cost-effective. The aim of this study was to assess the epidemiological effect and cost-effectiveness of the existing elderly and risk group vaccination programme under the new policy of mass

The Lancet. Public health2017 Full Text: Link to full Text with Trip Pro

70. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. BACKGROUND: Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation (...) on incidence of Hib disease. METHODS: Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar

Lancet2017

71. Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

Resistant influenza A viruses in children treated with oseltamivir: descriptive study. BACKGROUND: Oseltamivir is an effective inhibitor of influenza virus neuraminidase. Although viruses resistant to oseltamivir emerge less frequently than those resistant to amantadine or rimantadine, information on oseltamivir-resistant viruses arising during clinical use of the drug in children is limited. Our aim was to investigate oseltamivir resistance in a group of children treated for influenza. METHODS (...) : We analysed influenza A viruses (H3N2) collected from 50 children before and during treatment with oseltamivir. We sequenced the genes for neuraminidase and haemagglutinin and studied the mutant neuraminidases for their sensitivity to oseltamivir carboxylate. FINDINGS: We found neuraminidase mutations in viruses from nine patients (18%), six of whom had mutations at position 292 (Arg292Lys) and two at position 119 (Glu119Val), which are known to confer resistance to neuraminidase inhibitors. We

Lancet2017

73. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 WHO IRIS: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 Browse Related links Files in This Item: File Description Size Format 766.63 kB Adobe PDF Title: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 Authors: Issue Date: 2017 Publisher: World Health Organization (...) . Regional Office for Africa Journal: Influenza Virological Surveillance in the WHO African Region, 3 (41): 1-3 Place of publication: Brazzaville Language: English Description: 3 p. Keywords: Influenza A/H1N1pdm09 Subject: URI: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

74. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 WHO IRIS: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 Browse Related links Files in This Item: File Description Size Format 765.86 kB Adobe PDF Title: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 Authors: Issue Date: 2017 Publisher: World Health Organization. Regional Office (...) for Africa Journal: Influenza Virological Surveillance in the WHO African Region, 3 (43): 1-3 Place of publication: Brazzaville Language: English Description: 3 p. Subject: URI: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

75. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 WHO IRIS: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 Browse Related links Files in This Item: File Description Size Format 764.62 kB Adobe PDF Title: Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 Authors: Issue Date: 2017 Publisher: World Health Organization. Regional Office (...) for Africa Journal: Influenza Virological Surveillance in the WHO African Region, 3 (42): 1-3 Place of publication: Brazzaville Language: English Description: 3 p. Subject: URI: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017